RCT for Gambling and Naltrexone, Using Use Eye-tracking Analysis to Predict Treatment Response
Status:
Not yet recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to determine whether favorable response to naltrexone
orally taken in treatment of GD can be predicted by patterns of visual scanning, assessed by
eye-tracking technology before, at the start and throughout gambling treatment with
naltrexone.